Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim R Cressey

Showing results (31-40 of 166) with videos related to

Pageof 17
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1Tim R Cressey, Gonzague Jourdain, Marc J Lallemant, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2012
Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected Thai childrenTim R Cressey, Linda Aurpibul, Thition Narkbunnam, et al.
British Journal of Clinical Pharmacology|April 5, 2012
Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem, Tim R Cressey, Pattamawan Prapaithong, et al.
Virology Journal|April 16, 2021
Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrationsAyokunle O Olanrewaju, Benjamin P Sullivan, Ashley R Bardon, et al.
The Lancet. Child & Adolescent Health|October 22, 2021
One dose does not fit all: revising the WHO paediatric dosing tool to include the non-linear effect of body size and maturationPaolo Denti, Roeland E Wasmann, Jose Francis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV InfectionAhmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2009
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenSoranun Chantarangsu, Tim R Cressey, Surakameth Mahasirimongkol, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experienceMina Nikanjam, Desiré Kabamba, Tim R Cressey, et al.
Open Forum Infectious Diseases|September 10, 2025
Are Sex-Specific Cutoffs Needed With a Next-Generation Urine Tenofovir Lateral Flow Assay for Antiretroviral Adherence Monitoring?Xin Niu, Derin Sevenler, Sandy Dossantos, et al.
Clinical Pharmacokinetics|August 7, 2020
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIVAhizechukwu C Eke, Adeniyi Olagunju, Brookie M Best, et al.
Pageof 17

Showing results (31-40 of 166) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes (1999)|March 1, 2005
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1Tim R Cressey, Gonzague Jourdain, Marc J Lallemant, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 25, 2012
Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected Thai childrenTim R Cressey, Linda Aurpibul, Thition Narkbunnam, et al.
British Journal of Clinical Pharmacology|April 5, 2012
Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adultsChonlaphat Sukasem, Tim R Cressey, Pattamawan Prapaithong, et al.
Virology Journal|April 16, 2021
Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrationsAyokunle O Olanrewaju, Benjamin P Sullivan, Ashley R Bardon, et al.
The Lancet. Child & Adolescent Health|October 22, 2021
One dose does not fit all: revising the WHO paediatric dosing tool to include the non-linear effect of body size and maturationPaolo Denti, Roeland E Wasmann, Jose Francis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2025
Pharmacokinetics, Safety, Efficacy and Acceptability of Daclatasvir Plus Sofosbuvir in Young Children With Chronic HCV InfectionAhmed N Farrag, Maggie M Abbassi, Nirmeen A Sabry, et al.
The Journal of Antimicrobial Chemotherapy|October 9, 2009
Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai womenSoranun Chantarangsu, Tim R Cressey, Surakameth Mahasirimongkol, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2012
Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experienceMina Nikanjam, Desiré Kabamba, Tim R Cressey, et al.
Open Forum Infectious Diseases|September 10, 2025
Are Sex-Specific Cutoffs Needed With a Next-Generation Urine Tenofovir Lateral Flow Assay for Antiretroviral Adherence Monitoring?Xin Niu, Derin Sevenler, Sandy Dossantos, et al.
Clinical Pharmacokinetics|August 7, 2020
Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIVAhizechukwu C Eke, Adeniyi Olagunju, Brookie M Best, et al.
Pageof 17